Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates

Clinical and Vaccine Immunology

Volumn 14, Issue 2, 2007, Pages 198-200

  Davids, Virginia ^a   Hanekom, Willem ^a   Gelderbloem, Sebastian J ^a   Hawkridge, Anthony ^a   Hussey, Gregory ^a   Sheperd, Ronel ^a   Workman, Lesley ^a   Soler, Jorge ^b   Murray, Rose Ann ^b   Ress, Stanley R ^c   Kaplan, Gilla ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON;

ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; IMMUNE RESPONSE; INFANT; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NEWBORN CARE; PRIORITY JOURNAL; SCAR FORMATION;

BCG VACCINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INFANT; INFANT, NEWBORN; TUBERCULOSIS;

EID: 33947168222     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00309-06     Document Type: Article

References (24)

1. Anonymous. 2004. BCG vaccine. WHO position paper. Wkly. Epidemiol. Rec. 79:27-38.
2. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482-3489.
3. Behr, M. A., and P. M. Small. 1999. A historical and molecular phylogeny of BCG strains. Vaccine 17:915-922.
4. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162:5407-5416.
5. Casanova, J. L., and L. Abel. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20:581-620.
6. Castillo-Rodal, A. I., M. Castañón-Arreola, R. Hernández-Pando, J. J. Calva, E. Sada-Diaz, and Y. López- Vidal. 2006. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Infect. Immun. 74:1718-1724.
7. + T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69:2666-2674.
8. Chen, L., J. Wang, A. Zganiacz, and Z. Xing. 2004. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect. Immun. 72:238-246.
9. Corbel, M. J., U. Fruth, E. Griffiths, and I. Knezevic. 2004. Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London, 15-16 December 2003. Vaccine 22:2675-2680.
10. Davids, V., W. A. Hanekom, N. Mansoor, H. Gamieldien, S. J. Gelderbloem, A. Hawkridge, G. D. Hussey, E. J. Hughes, J. Soler, R. A. Murray, S. R. Ress, and G. Kaplan. 2006. The effect of bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants. J. Infect. Dis. 193:531-536.
11. Doffinger, R., S. Dupuis, C. Picard, C. Fieschi, J. Feinberg, G. Barcenas-Morales, and J. L. Casanova. 2002. Inherited disorders of IL-12- and IFN-gamma-mediated immunity: a molecular genetics update. Mol. Immunol. 38:903-909.
12. Goter-Robinson, C., S. C. Derrick, A. L. Yang, B. Y. Jeon, and S. L. Morris. 2006. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses. Vaccine 24:3522-3529.
13. Hanekom, W. A. 2005. The immune response to BCG vaccination of newborns. Ann. N. Y. Acad. Sci. 1062:69-78.
14. Hanekom, W. A., J. Hughes, M. Mavinkurve, M. Mendillo, M. Watkins, H. Gamieldien, S. J. Gelderbloem, M. Sidibana, N. Mansoor, V. Davids, R. A. Murray, A. Hawkridge, P. A. Haslett, S. Ress, G. D. Hussey, and G. Kaplan. 2004. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J. Immunol. Methods 291:185-195.
15. Hoft, D. F., S. Worku, B. Kampmann, C. C. Whalen, J. J. Ellner, C. S. Hirsch, R. B. Brown, R. Larkin, Q. Li, H. Yun, and R. F. Silver. 2002. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J. Infect. Dis. 186:1448-1457.
16. Hussey, G. D., M. L. Watkins, E. A. Goddard, S. Gottschalk, E. J. Hughes, K. Iloni, M. A. Kibel, and S. R. Ress. 2002. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 105:314-324.
17. Kemp, E. B., R. B. Belshe, and D. F. Hoft. 1996. Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guerin. J. Infect. Dis. 174:113-119.
18. Koscielniak, E., T. de Boer, S. Dupuis, L. Naumann, J. L. Casanova, and T. H. Ottenhoff. 2003. Disseminated Mycobacterium peregrinum infection in a child with complete interferon-gamma receptor-1 deficiency. Pediatr. Infect. Dis. J. 22:378-380.
19. Lowry, P. W., T. S. Ludwig, J. A. Adams, M. L. Fitzpatrick, S. M. Grant, G. A. Andrle, M. R. Offerdahl, S. N. Cho, and D. R. Jacobs, Jr. 1998. Cellular immune responses to four doses of percutaneous bacille Calmette-Guerin in healthy adults. J. Infect. Dis. 178:138-146.
20. Marchant, A., T. Goetghebuer, M. O. Ota, I. Wolfe, S. J. Ceesay, D. De Groote, T. Corrah, S. Bennett, J. Wheeler, K. Huygen, P. Aaby, K. P. McAdam, and M. J. Newport. 1999. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J. Immunol. 163:2249-2255.
21. Ordway, D. J., L. Costa, M. Martins, H. Silveira, L. Amaral, M. J. Arroz, F. A. Ventura, and H. M. Dockrell. 2004. Increased interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190:756-766.
22. Ottenhoff, T. H., T. De Boer, J. T. van Dissel, and F. A. Verreck. 2003. Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Adv. Exp. Med. Biol. 531:279-294.
23. Ravn, P., H. Boesen, B. K. Pedersen, and P. Andersen. 1997. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 158:1949-1955.
24. Turner, J., and I. M. Orme. 2004. The expression of early resistance to an infection with Mycobacterium tuberculosis by old mice is dependent on IFN type II (IFN-gamma) but not IFN type I. Mech. Ageing Dev. 125:1-9.